PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
Actinium Pharmaceuticals, Inc. (ATNM)
1.780.01 (-0.56%)
1.75 - 1.81
1.03 - 2.41
122.5K / 297.6K (Avg.)
-1.36 | -1.31
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
-116.92%
Negative EBIT growth while Healthcare median is 0.00%. Seth Klarman would check if external or internal factors caused the decline.
-185.87%
Negative operating income growth while Healthcare median is 0.00%. Seth Klarman would check if structural or cyclical issues are at play.
-92.79%
Negative net income growth while Healthcare median is 0.00%. Seth Klarman would investigate factors dragging net income down.
-3998.91%
Negative EPS growth while Healthcare median is 0.00%. Seth Klarman would explore whether share dilution or profit declines are to blame.
-3998.91%
Negative diluted EPS growth while Healthcare median is 0.00%. Seth Klarman would look for the cause: weakened profitability or heavier share issuance.
-95.29%
Share reduction while Healthcare median is 0.00%. Seth Klarman would see a relative advantage if others are diluting.
-95.29%
Diluted share reduction while Healthcare median is 0.00%. Seth Klarman would see an advantage if others are still diluting.
No Data
No Data available this quarter, please select a different quarter.
75.47%
OCF growth of 75.47% while Healthcare is zero. Walter Schloss might see a modest positive difference, which can compound over time.
66.24%
FCF growth of 66.24% while Healthcare median is zero. Walter Schloss might see a slight edge that could compound over time.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
-141.36%
Negative 10Y OCF/share CAGR while Healthcare median is 0.00%. Seth Klarman would suspect the firm is failing to keep pace with industry peers.
-420.27%
Negative 5Y OCF/share CAGR while Healthcare median is 0.00%. Seth Klarman might see a firm-specific issue if peers still expand cash flow.
-362.87%
Negative 3Y OCF/share CAGR while Healthcare median is 0.00%. Seth Klarman would check whether it’s cyclical or a firm-specific problem.
-427041.90%
Negative 10Y net income/share CAGR vs. Healthcare median of 31.49%. Seth Klarman might see a fundamental problem if peers maintain growth.
-659606.65%
Negative 5Y CAGR while Healthcare median is 14.40%. Seth Klarman might see a specific weakness if peers maintain profitable expansions.
-1088784.48%
Negative 3Y CAGR while Healthcare median is 4.68%. Seth Klarman might see a pressing concern if the rest of the sector is stable or growing.
No Data
No Data available this quarter, please select a different quarter.
-4964.64%
Negative 5Y equity/share growth while Healthcare median is 0.00%. Seth Klarman suspects firm-specific weaknesses if peers grow equity mid-term.
-1566.95%
Negative 3Y equity/share growth while Healthcare median is 0.00%. Seth Klarman sees a short-term weakness if peers still expand net worth.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
1993307.75%
Asset growth of 1993307.75% while Healthcare median is zero. Walter Schloss sees a slight advantage if expansions yield good returns on capital.
57821.37%
BV/share growth of 57821.37% while Healthcare is zero. Walter Schloss sees a slight lead that can expand if sustained over time.
2.24%
Debt growth of 2.24% while Healthcare median is zero. Walter Schloss might see a modest difference that matters if interest coverage is tight.
178.96%
R&D growth of 178.96% while Healthcare median is zero. Walter Schloss wonders if a slight increase yields a meaningful competitive edge.
203.49%
SG&A growth of 203.49% while Healthcare median is zero. Walter Schloss sees a modest overhead increase needing revenue justification.